These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 526409)

  • 41. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L; Florio P; Guerrieri P; Lanciotti G; Mastrocola C; Petrosillo N; Scarfò G; Avella A
    Clin Ter; 1981 Oct; 99(2):139-47. PubMed ID: 7032831
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 46. [Ergometric control in hypertension treatment with labetalol].
    Prohaska H; Honetz N
    Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661
    [No Abstract]   [Full Text] [Related]  

  • 47. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 50. [Labetalol in ambulatory therapy of hypertension].
    Zilcher H; Weber H; Glogar D
    Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
    [No Abstract]   [Full Text] [Related]  

  • 51. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

  • 52. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.
    Kristensen BO; la Cour Petersen E
    Postgrad Med J; 1980; 56 Suppl 2():57-9. PubMed ID: 7433344
    [No Abstract]   [Full Text] [Related]  

  • 56. A double-blind study with oral labetalol (Trandate)--a new hypotensive agent.
    Nontak MA; Ahmad S; Maheendran KK; Abdullah Z
    Singapore Med J; 1980 Feb; 21(1):474-8. PubMed ID: 6994236
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical evaluation of labetalol in essential hypertension. Effects of long-term treatment in conditions of rest and stress].
    Rossi A; Ziacchi V; Lomanto B
    Minerva Cardioangiol; 1980 Sep; 28(9):637-44. PubMed ID: 7007921
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hemodynamic study of a new injectable anti-hypertensive: labetalol].
    Clementy J; Dallocchio M
    Nouv Presse Med; 1978 Dec; 7(43):3934. PubMed ID: 733550
    [No Abstract]   [Full Text] [Related]  

  • 59. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I; Luetić V
    Lijec Vjesn; 1983; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract]   [Full Text] [Related]  

  • 60. Minoxidil and labetalol: very effective antihypertensive combination.
    Whiting G; Craswell P; Boyle P; Bett N
    Med J Aust; 1980 Mar; 1(5):225-6. PubMed ID: 7374568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.